|
- 2019
Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trialDOI: 10.1186/s13063-018-3169-3 Keywords: Gabapentin, Neuropathic pain, Children, Pharmacokinetics Abstract: The online version of this article (10.1186/s13063-018-3169-3) contains supplementary material, which is available to authorized users
|